ey0020.2-15 | New Perspectives | ESPEYB20
Z Li , R Veijola , E Koski , V Anand , F Martin , K Waugh , H Hyoty , C Winkler , MB Killian , M Lundgren , K Ng , M Maziarz , J Toppari
ey0020.3-2 | Novel Treatments for Rare Skeletal Disorders | ESPEYB20
VM Breinholt , PH Mygind , ED Christoffersen , Y Zhang , S Ota , R Will Charlton , D Viuff
ey0020.4-11 | Psychological Effects of Hormone Treatments | ESPEYB20
D Chen , J Berona , YM Chan , D Ehrensaft , R Garofalo , MA Hidalgo , SM Rosenthal , AC Tishelman , J Olson-Kennedy
ey0020.5-14 | Basic Research | ESPEYB20
V Prevot , M Tena-Sempere , N Pitteloud
ey0020.6-2 | New Mechanisms | ESPEYB20
MT Birnie , MDB Claydon , O Troy , BP Flynn , M Yoshimura , YM Kershaw , Z Zhao , RCR Demski-Allen , GRI Barker , EC Warburton , ZA Bortolotto , SL Lightman , BL Conway-Campbell
ey0020.8-1 | Clinical Trials – New Treatments | ESPEYB20
GP Forlenza , J McVean , RW Beck , C Bauza , R Bailey , B Buckingham , LA DiMeglio , JL Sherr , M Clements , A Neyman , C Evans-Molina , EK Sims , LH Messer , L Ekhlaspour , R McDonough , M Van Name , D Rojas , S Beasley , S DuBose , C Kollman , A Moran , CLVer Study Group
ey0020.9-11 | Obesity as a Brain Disease | ESPEYB20
SE Thanarajah , AG DiFeliceantonio , K Albus , B Kuzmanovic , L Rigoux , S Iglesias , R Hanszen , M Schlamann , OA Cornely , JC Bruning , M Tittgemeyer , DM Small
ey0020.9-13 | Obesity and Insulin/Glucose Metabolism | ESPEYB20
R Halloun , A Galderisi , S Caprio , R Weiss
ey0018.4-13 | New Paradigms | ESPEYB18
A Dauber , Y Meng , L Audi , S Vedantam , B Weaver , A Carrascosa , K Albertsson-Wikland , M Ranke , A Jorge , J Cara , MP Wajnrajch , A Lindberg , C Camacho-Hübner , JN Hirschhorn
ey0018.7-1 | Clinical Guidance | ESPEYB18
D Helvacıoğlu , S Demircioğlu Turan , T Guran , Z Atay , A Dağcınar , D Bezen , E Karakılıc Ozturan , F Darendeliler , A Yuksel , F Dursun , S Kılınc , S Semiz , S Abalı , M Yıldız , A Onder , A Bereket